staurosporine has been researched along with floxuridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardinale, I; Sehgal, PB; Tamm, I | 1 |
| Elliott, MJ; Lock, RB; Stribinskiene, L | 1 |
| Danenberg, KD; Danenberg, PV; Grem, JL; Kao, V; Nguyen, D | 1 |
| Bonner, WM; D'Ambrosio, E; Kumari, D; Nakamura, AJ; Somma, V; Usdin, K | 1 |
4 other study(ies) available for staurosporine and floxuridine
| Article | Year |
|---|---|
Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alkaloids; Antibodies, Monoclonal; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Line; Cell Movement; Cytokines; DNA Replication; Drug Synergism; Female; Floxuridine; Growth Substances; Humans; Interleukin-6; Methotrexate; Protein Kinase C; Recombinant Proteins; Second Messenger Systems; Staurosporine; Tetradecanoylphorbol Acetate | 1991 |
Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin.
Topics: Antineoplastic Agents; Apoptosis; Cell Survival; DNA Fragmentation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Floxuridine; HeLa Cells; Humans; Proto-Oncogene Proteins c-bcl-2; Staurosporine | 1998 |
Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
Topics: Alkaloids; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Deoxyribonucleotides; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Drug Combinations; Enzyme Inhibitors; Floxuridine; Genes, p53; Humans; Lung Neoplasms; Polymerase Chain Reaction; RNA, Messenger; Staurosporine; Thymidylate Synthase; Tumor Cells, Cultured | 2002 |
The role of DNA damage response pathways in chromosome fragility in Fragile X syndrome.
Topics: Aphidicolin; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Chromosome Breakage; Chromosome Fragile Sites; Chromosome Fragility; DNA Damage; DNA Repair; DNA-Binding Proteins; Floxuridine; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Knockdown Techniques; Histones; Humans; Male; Morpholines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrones; Staurosporine; Tumor Suppressor Proteins | 2009 |